Latest 8-K filings

NYSE
ITT Inc. reported record Q2 revenue of $1.5 billion, up 51% year-over-year, driven by the SPX FLOW acquisition and organic growth, leading to raised full-year guidance.
NASDAQ
Lexicon Pharmaceuticals announced second quarter 2026 financial results, highlighting completed enrollment in its SONATA-HCM study and progress on its ZYNQUISTA NDA resubmission.
NASDAQ
MACOM Technology Solutions Holdings, Inc. announced robust financial results for its fiscal third quarter ended July 3, 2026, showcasing substantial revenue and profit growth.
NASDAQ
Collegium Pharmaceutical announced strong second-quarter 2026 results, with net revenues up 6% year-over-year, driven by significant growth in its ADHD portfolio, particularly JORNAY PM, and the successful acquisition of AZSTARYS.
NASDAQ
Cronos Group Inc. announced record net revenue, gross profit, and Adjusted EBITDA for Q2 2026, driven by strong performance in Canada, Israel, and Germany, alongside a significant share repurchase program.
Optimum Communications announced its second quarter 2026 financial results, reporting a year-over-year revenue decrease of 5.8% to $2.02 billion and a net loss of $291.8 million.
NYSE
Cheniere Energy Partners, L.P. announced robust second quarter 2026 financial results, including significant increases in revenue, net income, and Adjusted EBITDA, while reconfirming full-year distribution guidance.
NYSE
Installed Building Products announced second quarter 2026 results, showing record revenue of $777.8 million, a 2.3% increase year-over-year, alongside a regular quarterly cash dividend declaration.
NYSE
RE/MAX Holdings, Inc. and The Real Brokerage Inc. provide an update on their merger, detailing director appointments, committee structures, and upcoming shareholder meetings.
NYSE
Cheniere Energy reported strong second quarter 2026 results, highlighted by operational milestones and a significant increase in full-year financial guidance for Adjusted EBITDA and Distributable Cash Flow.
OQB
The Dixie Group reported stable net sales for Q2 2026, with modest improvements in gross profit margins, though net income per diluted share decreased slightly year-over-year.
NYSE
Curtiss-Wright Corporation announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year financial guidance.
NYSE
Genie Energy reported a substantial increase in net income and EPS for Q2 2026, driven by improved gross margins in its retail energy segment.
NASDAQ
Compass Therapeutics announced its second quarter 2026 financial results, detailing progress in its oncology drug pipeline and maintaining a cash runway into 2028.
NASDAQ
Priority Technology Holdings, Inc. announced its second quarter 2026 financial results, showcasing a 9.4% year-over-year revenue increase to $262.3 million and affirming its full-year 2026 financial guidance.
NYSE
Nuvation Bio announced robust second quarter 2026 financial results, showcasing significant revenue growth for IBTROZI and positive advancements in its safusidenib clinical program.
NYSE
Genesis Energy LP announced robust second quarter 2026 financial results, marked by a significant increase in net income and cash flow, alongside strategic balance sheet enhancements.
NYSE
Six Flags Entertainment Corporation reported its 2026 second-quarter results, highlighting increased attendance and Adjusted EBITDA on a same-park basis, alongside growth in its active pass base.
NASDAQ
Safe Pro Group Inc. announced a new $780,000 purchase order from a Department of War Prime Contractor for AI-powered threat detection and drones.
NYSE
ConocoPhillips announced robust second-quarter 2026 financial and operational results, highlighted by a significant increase in earnings, substantial cash flow generation, and a doubling of share repurchases.
OQB
The Dixie Group, Inc. has released an updated investor presentation highlighting its focus on the high-end residential flooring market, while acknowledging significant industry challenges and ongoing cost reduction efforts.
NASDAQ
Tarsus Pharmaceuticals announced robust second quarter 2026 financial results, with XDEMVY net sales surging 69% year-over-year, leading to an increased full-year sales forecast and strategic pipeline expansion.
NYSE
Nuveen Churchill Direct Lending Corp. reported Q2 2026 net investment income of $0.41 per share, declared a $0.38 per share distribution, and took strategic steps to optimize its balance sheet.
NASDAQ
Appian announced robust second quarter 2026 financial results, highlighted by a 23% year-over-year increase in cloud subscriptions revenue and a significant improvement in operating income and net income on a non-GAAP basis.
NASDAQ
Cogent Communications announced Q2 2026 results, highlighting a $130.7 million gain from data center sales and a decline in net leverage ratio.
NASDAQ
Sotera Health announced robust second-quarter 2026 financial results, exceeding expectations and prompting an upward revision of its full-year 2026 outlook.
NASDAQ
Driven Brands Holdings Inc. announced second quarter 2026 results, showcasing a 6.8% revenue increase to $507.4 million and sustained same-store sales growth, while reiterating its fiscal year outlook.
NASDAQ
Precision BioSciences announced second quarter 2026 financial results, highlighting key clinical advancements in its PBGENE-HBV and PBGENE-DMD programs, and a cash runway extending through 2028.
NYSE
FrontView REIT announced robust second quarter 2026 results, including a raise in its full-year AFFO per share guidance and increased net investment targets.
NASDAQ
Harrow, Inc. announced its definitive agreement to acquire the global rights to TYRVAYA (varenicline solution) nasal spray from Viatris Inc., expanding its dry eye disease portfolio.